You can view the current or previous issues of Diabetes Health online, in their entirety, anytime you want.
Click Here To View
See if you qualify for our free healthcare professional magazines. Click here to start your application for Pre-Diabetes Health, Diabetes Health Pharmacist and Diabetes Health Professional.
Latest Insulin Articles
Popular Insulin Articles
Highly Recommended Insulin Articles
Send a link to this page to your friends and colleagues.
Giving intensive insulin therapy to patients with elevated blood-glucose levels in the surgical intensive care unit (ICU) of a hospital significantly reduces their chance of death, even if the patients did not previously have diabetes, say researchers in Belgium. Greet Van den Berghe, MD, PhD, and colleagues reported their results in the November 8, 2001, issue of The New England Journal of Medicine.
In a prospective, randomized, controlled study, researchers tested intensive insulin therapy on 1,548 surgical ICU patients for a period of 12 months. The patients were assigned to receive either intensive insulin therapy (maintaining their blood-glucose levels between 80 and 110 mg/dl) or conventional treatment (receiving insulin only if blood-glucose levels were higher than 215 mg/dl and keeping levels between 180 and 200 mg/dl). Novo Nordisk's Novolin insulin was used.
Of the conventionally treated patients who remained in ICU for more than five days, 8 percent died, compared to a 4.6 percent death rate among those who received intensive insulin treatment. Hospitalwide, there were 34 percent fewer deaths in intensively treated patients. In addition, 46 percent fewer of those patients had bloodstream infections; there were 50 percent fewer transfusions; renal failure requiring dialysis decreased 41 percent; critical illness polyneuropathy decreased 44 percent; and patients were less likely to need respiratory support.
"Intensive insulin therapy to maintain blood glucose at or below 110 mg/dl reduces morbidity and mortality among critically ill patients in the surgical intensive care unit," the researchers conclude.
Categories: Blood Glucose, Diabetes, Diabetes, Hospital Care, Insulin, Novo Nordisk
Diabetes Health is the essential resource for people living with diabetes- both newly diagnosed and experienced as well as the professionals who care for them. We provide balanced expert news and information on living healthfully with diabetes. Each issue includes cutting-edge editorial coverage of new products, research, treatment options, and meaningful lifestyle issues.

Comments
Add your comments about this article below. You can add comments as a registered user or anonymously. If you choose to post anonymously your comments will be sent to our moderator for approval before they appear on this page. If you choose to post as a registered user your comments will appear instantly.
When voicing your views via the comment feature, please respect the Diabetes Health community by refraining from comments that could be considered offensive to other people. Diabetes Health reserves the right to remove comments when necessary to maintain the cordial voice of the diabetes community.
For your privacy and protection, we ask that you do not include personal details such as address or telephone number in any comments posted.
Don't have your Diabetes Health Username? Register now and add your comments to all our content.
Register...
Register your Diabetes Health Username here.
Have Your Say...